• TRPM3 Regulation by Neurosteroids and Primidone

  2026-08-13

  The reference study combines cryo-EM structures, electrophysiology, molecular dynamics, and biochemical analysis to define how pregnenolone sulfate, CIM 0216, and primidone regulate TRPM3. Its structural framework connects ligand recognition with channel gating and disease-associated gain-of-function mutations, while also clarifying the therapeutic rationale for TRPM3 inhibition.

• Fenofibrate, PPARα–YAP Signaling, and Liver Aging

  2026-08-12

  The reference study shows that Fenofibrate induces comparable liver enlargement and PPARα–YAP pathway activation in adult and aging mouse models. Its main innovation is the use of complementary aging systems to demonstrate that hepatocyte enlargement, proliferation, and pathway responses remain broadly age-independent, while also highlighting important limits for translating mouse findings to older patients.

• Amiloride (MK-870): From Ion Channels to Translation

  2026-08-12

  Amiloride (MK-870) is more than an epithelial sodium channel probe: used with orthogonal controls, it can help translational researchers distinguish ion-transport effects from receptor trafficking and endocytic mechanisms. Evidence from grass carp reovirus entry illustrates why both positive and negative pharmacology matter.

• DiscoveryProbe Bioactive Compound Library: Mechanistic Scree

  2026-08-11

  DiscoveryProbe Bioactive Compound Library Plus enables mechanism-first screening across diverse signaling pathways. This article explains how to combine its chemically broad perturbation space with thermal shift assays, orthogonal binding tests, and cellular validation to distinguish pathway activity from direct target engagement.

• Angiotensin II (A1042): Practical Protocol Guide

  2026-08-10

  Angiotensin II (SKU A1042; Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) provides a defined peptide stimulus for receptor signaling, vascular cell, and remodeling workflows. This guide covers preparation and starting conditions for research use, but the material should not be used for diagnosis, treatment, or unvalidated clinical applications.

• Imatinib (STI571) in PDGFR Remodeling Assays

  2026-08-09

  Imatinib (STI571) can serve as a mechanistic comparator in PDGFR-driven vascular remodeling studies. This article connects kinase engagement, MAP kinase pathway inhibition, and phenotype-level assay design while defining the limits of cross-domain interpretation.

• ALDH2 Activation Delays Heart Failure in Mice

  2026-08-08

  The reference study identifies ALDH2 as a regulator of cardiomyocyte proliferation, not only as a mitochondrial enzyme involved in oxidative stress control. In neonatal and pressure-overloaded mouse hearts, pharmacological ALDH2 activation extended cardiomyocyte proliferation and delayed heart-failure progression, suggesting a regenerative mechanism that complements conventional cardioprotection.

• Losartan Workflows for Hypertension and Tumor Biology

  2026-08-07

  Losartan provides a controlled way to dissect AT1-receptor signaling in vascular smooth muscle, blood-pressure models, and collagen-rich tumor microenvironments. This workflow-focused guide connects concentration planning, mechanistic readouts, and troubleshooting with emerging evidence on angiotensin receptor blockade and immune checkpoint therapy.

• Alda 1 and ALDH2 Activation: New Frontiers in Cardiac Regene

  2026-08-07

  Explore how Alda 1, a potent ALDH2 activator from APExBIO, is redefining the landscape of cardiac regeneration and translational research. This thought-leadership article delivers a synthesis of mechanistic insights, in vivo validation, and strategic guidance for researchers aiming to translate ALDH2-targeted interventions from bench to bedside—moving beyond infarct size reduction toward true regenerative capacity.

• Caspase-8 Fluorometric Assay Kit: Precision Tools for Apopto

  2026-08-06

  Explore the Caspase-8 Fluorometric Assay Kit for advanced measurement of cysteine-dependent aspartate-directed protease activity. This article provides original insights into assay-driven research on apoptosis, pyroptosis, and neurodegeneration, integrating new mechanistic findings and rigorous protocol guidance.

• 3X (DYKDDDDK) Peptide: Precision Tag for Protein Purificatio

  2026-08-06

  The 3X (DYKDDDDK) Peptide, also known as the 3X FLAG peptide, is a synthetic epitope tag that enables highly sensitive affinity purification and immunodetection of recombinant proteins. Its triple-repeat hydrophilic sequence enhances antibody recognition, supports advanced structural biology, and facilitates robust workflows in molecular research.

• Lyotropic Self-Assembly of Coil-Bottlebrush Diblocks in Ioni

  2026-08-05

  Rodriguez et al. present a systematic investigation of coil-bottlebrush diblock copolymer self-assembly in alkylimidazolium-based ionic liquids, revealing that lyotropic phase behavior is only weakly affected by the ionic liquid's alkyl chain length. This finding broadens design flexibility for nanostructured materials in ion-rich environments, with direct implications for membrane and energy device development.

• Diphenyleneiodonium Chloride: Advanced Redox and cAMP Assay

  2026-08-05

  Explore how Diphenyleneiodonium chloride (DPI) uniquely enables robust cAMP signaling modulation and redox enzyme function studies. This article dives deeper into Nrf2 pathway dynamics, experimental nuances, and assay optimization, offering unmatched practical guidance for oxidative stress research.

• Amyloid Beta-peptide (25-35): Advanced Neurotoxicity Modelin

  2026-08-04

  Amyloid Beta-peptide (25-35) (Aβ25-35) enables precise, reproducible modeling of Alzheimer's neurotoxicity and microglial polarization. Leveraging APExBIO's rigorously benchmarked peptide, researchers achieve new clarity in dissecting neurodegenerative mechanisms and testing therapeutic strategies.

• ICAA Targets RIP3 to Inhibit Angiotensin II-Induced Cardiac

  2026-08-04

  This study demonstrates that isochlorogenic acid A (ICAA) directly inhibits RIP3, suppressing the RIP3/CaMKII pathway to attenuate angiotensin II-induced cardiac hypertrophy in both in vitro and in vivo models. The findings introduce RIP3 as a promising therapeutic target, offering new mechanistic insight and potential for more precise cardiovascular disease interventions.

449 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page